Serial ctDNA and Molecular Residual Disease Monitoring in Neuroblastoma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Serial ctDNA and Molecular Residual Disease Monitoring in Neuroblastoma — Stella

Home/Neuroblastoma/

View on ClinicalTrials.gov

Recruiting

Back to Neuroblastoma trials

Trial locations(1 site)

China

Sun Yat-sen University Cancer Center, Guangzhou, Guangdong

Key details

Sponsor

Sun Yat-sen University

Enrollment target

~200 participants

Started

January 2022

Primary completion

December 2026

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.